Identifying and definitional attributes
|Item type:||Data Source|
The Australian Needle and Syringe Program Survey (ANSPS) provides serial point prevalence estimates of HIV and hepatitis C virus (HCV) antibody prevalence, HCV RNA prevalence and monitors sexual and injecting behaviour among people who inject drugs (PWID) in Australia.
The ANSPS is conducted annually at more than 50 needle and syringe program (NSP) services over a one to two week period in October each year. The project is conducted in all states and territories and recruits between 2,000 – 2,500 NSP attendees each year. Participants complete a brief self-administered questionnaire and provide a capillary blood sample which is subsequently tested for HIV and hepatitis C antibodies and HCV RNA.
This project is supported by the Australian Government Department of Health
Project collaborators are:
|Link to data source:|
Collection and usage attributes
|National reporting arrangement:|
|Implementation start date:||01/06/1996|
The first survey was taken in a week in March 1995.
Source and reference attributes
The Kirby Institute, University of New South Wales
|Data custodian contact details:|
Level 6, Wallace Wurth Building
+61 (2) 9385 0900
+61 (2) 9385 0920